Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Brain Barrier Defect: full-pipeline trial registry
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Blood Brain Barrier Defect: 2 US clinical trials tracked, none currently recruiting.
Blood Brain Barrier Defect is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Guerbet, running 1 of these trials.
Enrollment posture brief
Registry condition blood-brain-barrier-defect
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Blood Brain Barrier Defect has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blood Brain Barrier Defect on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blood Brain Barrier Defect is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
University of Southern California
NCT04876638
Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Guerbet
NCT03996447
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Blood Brain Barrier Defect records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blood Brain Barrier Defect trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blood Brain Barrier Defect page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Blood Brain Barrier Defect trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Guerbet sponsors the most Blood Brain Barrier Defect trials on record, review their full trial history before evaluating a specific study. See Guerbet's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Brain Barrier Defect condition card totals 2 registered trials; most-linked intervention Gadobutrol 1Mmol/mL Solution for Injection Vial; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.